F.D.A. Speeds Review of Gene Therapies, Vowing to Target Rogue Clinics

NYT, 17 November 2017
Authors: Sheila Kaplan, Denise Grady
“The Food and Drug Administration on Thursday issued new guidelines to speed the introduction of treatments involving human cells and tissues, including gene therapy. But the agency also said it would crack down on rogue clinics offering dangerous or unproven versions of those treatments.”
Find article here.